3 research outputs found
Children With Autism Spectrum Disorder: Assessing the Relationship Between Services Received and Quality of Life
This study was designed to explore the relationship between the quality of life of children on the autism spectrum and the services they are receiving. Although there are groups of people who do not believe that children on the spectrum are in need of treatment, therapies have become the expected following a diagnosis of autism spectrum disorder. The aim of this study was to identify whether certain types of therapies and services were associated with better quality of life for children with autism. An anonymous survey was distributed online to individuals within the autism spectrum disorder community. Participants were parents of one child on the spectrum (2-12 years old); 47 individuals completed the survey. Results indicated that certain therapies are associated with reported improvement in some categories but not others. Applied Behavioral Analysis therapy was associated with reported ability to communicate, happiness in public, and happiness at school. Speech therapy was associated with reported improvement in a child’s ability to perform physical tasks. Understanding the relationship between the types of service received or the amount of time participating in services and reported improvement levels in various areas of life will inform health care professionals’ perspective regarding the value of therapies. Genetic counselors serve a unique role because they are often the team member first connecting with the family and helping initiate services. This research broadens the understanding of the impact that therapies may have on quality of life and enhance the ability of professionals to provide guidance to families
De novo and inherited variants in ZNF292 underlie a neurodevelopmental disorder with features of autism spectrum disorder
International audiencePURPOSE:Intellectual disability (ID) and autism spectrum disorder (ASD) are genetically heterogeneous neurodevelopmental disorders. We sought to delineate the clinical, molecular, and neuroimaging spectrum of a novel neurodevelopmental disorder caused by variants in the zinc finger protein 292 gene (ZNF292).METHODS:We ascertained a cohort of 28 families with ID due to putatively pathogenic ZNF292 variants that were identified via targeted and exome sequencing. Available data were analyzed to characterize the canonical phenotype and examine genotype-phenotype relationships.RESULTS:Probands presented with ID as well as a spectrum of neurodevelopmental features including ASD, among others. All ZNF292 variants were de novo, except in one family with dominant inheritance. ZNF292 encodes a highly conserved zinc finger protein that acts as a transcription factor and is highly expressed in the developing human brain supporting its critical role in neurodevelopment.CONCLUSION:De novo and dominantly inherited variants in ZNF292 are associated with a range of neurodevelopmental features including ID and ASD. The clinical spectrum is broad, and most individuals present with mild to moderate ID with or without other syndromic features. Our results suggest that variants in ZNF292 are likely a recurrent cause of a neurodevelopmental disorder manifesting as ID with or without ASD
Recurrent de novo missense variants across multiple histone H4 genes underlie a neurodevelopmental syndrome
Chromatin is essentially an array of nucleosomes, each of which consists of the DNA double-stranded fiber wrapped around a histone octamer. This organization supports cellular processes such as DNA replication, DNA transcription, and DNA repair in all eukaryotes. Human histone H4 is encoded by fourteen canonical histone H4 genes, all differing at the nucleotide level but encoding an invariant protein. Here, we present a cohort of 29 subjects with de novo missense variants in six H4 genes (H4C3, H4C4, H4C5, H4C6, H4C9, and H4C11) identified by whole-exome sequencing and matchmaking. All individuals present with neurodevelopmental features of intellectual disability and motor and/or gross developmental delay, while non-neurological features are more variable. Ten amino acids are affected, six recurrently, and are all located within the H4 core or C-terminal tail. These variants cluster to specific regions of the core H4 globular domain, where protein-protein interactions occur with either other histone subunits or histone chaperones. Functional consequences of the identified variants were evaluated in zebrafish embryos, which displayed abnormal general development, defective head organs, and reduced body axis length, providing compelling evidence for the causality of the reported disorder(s). While multiple developmental syndromes have been linked to chromatin-associated factors, missense-bearing histone variants (e.g., H3 oncohistones) are only recently emerging as a major cause of pathogenicity. Our findings establish a broader involvement of H4 variants in developmental syndromes